Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KRP-114V Phase III Study in Pediatric Overactive Bladder
jRCT2011260024Phase 3Recruiting
- Sponsor
- Kyorin Pharmaceutical
- Start
- Jul 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in overactive bladder (OAB) comparing KRP-114V arm with Placebo arm (2 arms). Started Jul 2026; status: recruiting.
02
Drugs
vibegron
03
Conditions
overactive bladder (OAB)
Beyond the preview
Go deeper on jRCT2011260024.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2011260024.